Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2009, Article ID 793281, 14 pages
http://dx.doi.org/10.1155/2009/793281
Research Article

Dynamic Changes of Neuroskeletal Proteins in DRGs Underlie Impaired Axonal Maturation and Progressive Axonal Degeneration in Type 1 Diabetes

1Department of Pathology, School of Medicine, Wayne State University, Detroit, MI 48201, USA
2Department of Endocrinology and Diabetes, Graduate School of Medicine, Nagoya University, Nagoya 466-8550, Japan
3Department of Neurology, School of Medicine, Wayne State University, Detroit, MI 48201, USA

Received 3 February 2009; Accepted 7 July 2009

Academic Editor: Jiro Nakamura

Copyright © 2009 Hideki Kamiya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. A. F. Sima, “Pathological mechanisms involved in diabetic neuropathy: can we slow the process?” Current Opinion in Investigational Drugs, vol. 7, no. 4, pp. 324–337, 2006. View at Google Scholar
  2. A. A. F. Sima and H. Kamiya, “Is C-peptide replacement the missing link for successful treatment of neurological complications in type 1 diabetes?” Current Drug Targets, vol. 9, pp. 37–46, 2008. View at Google Scholar
  3. D. A. Greene, S. A. Lattimer, and A. A. F. Sima, “Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications,” The New England Journal of Medicine, vol. 316, no. 10, pp. 599–606, 1987. View at Google Scholar
  4. R. Pop-Busui, A. A. F. Sima, and M. Stevens, “Diabetic neuropathy and oxidative stress,” Diabetes/Metabolism Research and Reviews, vol. 22, no. 4, pp. 257–273, 2006. View at Publisher · View at Google Scholar
  5. J. Wahren, K. Ekberg, J. Johansson et al., “Role of C-peptide in human physiology,” American Journal of Physiology, vol. 278, pp. E759–E768, 2000. View at Google Scholar
  6. C. R. Pierson, W. Zhang, and A. A. F. Sima, “Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration,” Journal of Neuropathology and Experimental Neurology, vol. 62, no. 7, pp. 765–779, 2003. View at Google Scholar
  7. Z. G. Li, W. Zhang, and A. A. F. Sima, “C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells,” Diabetes/Metabolism Research and Reviews, vol. 19, no. 5, pp. 375–385, 2003. View at Publisher · View at Google Scholar
  8. A. A. F. Sima, W. Zhang, Z. G. Li, Y. Murakawa, and C. R. Pierson, “Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide,” Diabetes, vol. 53, no. 6, pp. 1556–1563, 2004. View at Publisher · View at Google Scholar
  9. H. Kamiya, Y. Murakawa, W. Zhang, and A. A. F. Sima, “Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes,” Diabetes/Metabolism Research and Reviews, vol. 21, no. 5, pp. 448–458, 2005. View at Publisher · View at Google Scholar
  10. P. J. Dyck, J. L. Davies, D. M. Wilson, F. J. Service, L. J. Melton III, and P. C. O'Brien, “Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort,” Diabetes Care, vol. 22, no. 9, pp. 1479–1486, 1999. View at Publisher · View at Google Scholar
  11. A. A. F. Sima, V. Nathaniel, V. Bril, T. A. J. McEwen, and D. A. Greene, “Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy,” The Journal of Clinical Investigation, vol. 81, no. 2, pp. 349–364, 1988. View at Google Scholar
  12. A. A. F. Sima, W. Zhang, G. Xu, K. Sugimoto, D. Guberski, and M. A. Yorek, “A comparison of diabetic polyneuropathy in type-2 diabetic BBZDR/Wor rats and in type-1 diabetic BB/Wor rats,” Diabetologia, vol. 43, pp. 786–793, 2000. View at Google Scholar
  13. A. A. F. Sima, “New insights into the metabolic and molecular basis for diabetic neuropathy,” Cellular and Molecular Life Sciences, vol. 60, pp. 2445–2464, 2003. View at Publisher · View at Google Scholar
  14. A. A. F. Sima and H. Kamiya, “Diabetic neuropathy differs in type 1 and type 2 diabetes,” Annals of the New York Academy of Sciences, vol. 1084, pp. 235–249, 2006. View at Publisher · View at Google Scholar
  15. P. N. Hoffman, D. W. Cleveland, J. W. Griffin, P. W. Landes, N. J. Cowan, and D. L. Price, “Neurofilament gene expression: a major determinant of axonal caliber,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 10, pp. 3472–3476, 1987. View at Google Scholar
  16. D. R. Archer, D. F. Watson, and J. W. Griffin, “Phosphorylation-dependent immunoreactivity of neurofilaments and the rate of slow axonal transport in the central and peripheral axons of the rat dorsal root ganglion,” Journal of Neurochemistry, vol. 62, no. 3, pp. 1119–1125, 1994. View at Google Scholar
  17. S. Yagihashi, M. Kamijo, and K. Watanabe, “Reduced myelinated fiber size correlates with loss of axonal neurofilaments in peripheral nerve of chronically streptozotocin diabetic rats,” American Journal of Pathology, vol. 136, no. 6, pp. 1365–1373, 1990. View at Google Scholar
  18. L. Mohiuddin, P. Fernyhough, and D. R. Tomlinson, “Reduced levels of mRNA encoding endoskeletal and growth-associated proteins in sensory ganglia in experimental diabetes,” Diabetes, vol. 44, no. 1, pp. 25–30, 1995. View at Google Scholar
  19. J. N. Scott, A. W. Clark, and D. W. Zochodne, “Neurofilament and tubulin gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons,” Brain, vol. 122, no. 11, pp. 2109–2117, 1999. View at Publisher · View at Google Scholar
  20. N. M. Sayers, L. J. Beswick, A. Middlemas et al., “Neurotrophin-3 prevents the proximal accumulation of neurofilament proteins in sensory neurons of streptozocin-induced diabetic rats,” Diabetes, vol. 52, no. 9, pp. 2372–2380, 2003. View at Publisher · View at Google Scholar
  21. P. Fernyhough, A. Gallagher, S. A. Averill et al., “Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy,” Diabetes, vol. 48, no. 4, pp. 881–889, 1999. View at Google Scholar
  22. P. Fernyhough and R. E. Schmidt, “Neurofilaments in diabetic neuropathy,” International Review of Neurobiology, vol. 50, pp. 115–144, 2002. View at Google Scholar
  23. H. Kamiya, W. Zhang, K. Ekberg, J. Wahren, and A. A. F. Sima, “C-peptide reverses nociceptive neuropathy in type 1 diabetes,” Diabetes, vol. 55, no. 12, pp. 3581–3587, 2006. View at Publisher · View at Google Scholar
  24. B. S. Li, Veeranna, J. Gu, P. Grant, and H. C. Pant, “Activation of mitogen-activated protein kinases (Erk1 and Erk2) cascade results in phosphorylation of NF-M tail domains in transfected NIH 3T3 cells,” European Journal of Biochemistry, vol. 262, no. 1, pp. 211–217, 1999. View at Publisher · View at Google Scholar
  25. J. Brownlees, A. Yates, N. P. Bajaj et al., “Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3,” Journal of Cell Science, vol. 113, no. 3, pp. 401–407, 2000. View at Google Scholar
  26. C. R. Pierson, W. Zhang, Y. Murakawa, and A. A. F. Sima, “Insulin deficiency rather than hyperglycemia accounts for impaired neurotrophic responses and nerve fiber regeneration in type 1 diabetic neuropathy,” Journal of Neuropathology and Experimental Neurology, vol. 62, no. 3, pp. 260–271, 2003. View at Google Scholar
  27. J. Nunez and I. Fischer, “Microtubule-associated proteins (MAPs) in the peripheral nervous system during development and regeneration,” Journal of Molecular Neuroscience, vol. 8, no. 3, pp. 207–222, 1997. View at Google Scholar
  28. H. Jiang, W. Guo, X. Liang, and Y. Rao, “Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3β and its upstream regulators,” Cell, vol. 120, pp. 123–135, 2005. View at Publisher · View at Google Scholar
  29. F.-Q. Zhou and W. D. Snider, “GSK-3β and microtubule assembly in axons,” Science, vol. 308, no. 5719, pp. 211–214, 2005. View at Publisher · View at Google Scholar
  30. J. P. Mordes, R. Bortell, H. Groes, D. Guberski, A. A. Rossini, and D. L. Greiner, “Autoimmune diabetes mellitus in the BB rat,” in Animal Models of Diabetes, A. A. F. Sima and E. Shafrir, Eds., pp. 1–42, Harwood Academic, Amsterdam, The Netherlands, 2001. View at Google Scholar
  31. A. A. F. Sima, M. Bouchier, and H. Christensen, “Axonal atrophy in sensory nerves of the diabetic BB-Wistar rat: a possible early correlate of human diabetic neuropathy,” Annals of Neurology, vol. 13, no. 3, pp. 264–272, 1983. View at Google Scholar
  32. Z. G. Li, W. Zhang, G. Grunberger, and A. A. F. Sima, “Hippocampal neuronal apoptosis in type 1 diabetes,” Brain Research, vol. 946, no. 2, pp. 221–231, 2002. View at Publisher · View at Google Scholar
  33. H. Kamiya, W. Zhang, and A. A. F. Sima, “C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes,” Annals of Neurology, vol. 56, pp. 827–835, 2004. View at Publisher · View at Google Scholar
  34. A. A. F. Sima, W. Zhang, K. Sugimoto et al., “C-peptide prevents and improves chronic type I diabetic polyneuropathy in the BB/Wor rat,” Diabetologia, vol. 44, pp. 889–897, 2001. View at Publisher · View at Google Scholar
  35. G. Xu, C. R. Pierson, Y. Murakawa, and A. A. F. Sima, “Altered tubulin and neurofilament expression and impaired axonal growth in diabetic nerve regeneration,” Journal of Neuropathology and Experimental Neurology, vol. 61, no. 2, pp. 164–175, 2002. View at Google Scholar
  36. C. R. Pierson, W. Zhang, Y. Murakawa, and A. A. F. Sima, “Early gene responses of trophic factors in nerve regeneration differ in experimental type 1 and type 2 diabetic polyneuropathies,” Journal of Neuropathology and Experimental Neurology, vol. 61, pp. 857–871, 2002. View at Google Scholar
  37. H. C. Pant, Veeranna, and P. Grant, “Regulation of axonal neurofilament phosphorylation,” Current Topics in Cellular Regulation, vol. 36, pp. 133–150, 2000. View at Google Scholar
  38. K. Sugimoto, Y. Murakawa, and A. A. F. Sima, “Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord,” Journal of the Peripheral Nervous System, vol. 7, pp. 44–53, 2002. View at Publisher · View at Google Scholar
  39. D. W. Zochodne, V. M. K. Verge, C. Cheng, H. Sun, and J. Johnston, “Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes,” Brain, vol. 124, pp. 2319–2334, 2001. View at Google Scholar
  40. K. J. Burchiel, L. C. Russell, R. P. Lee, and A. A. F. Sima, “Spontaneous activity of primary afferent neurons in diabetic BB/Wistar rats: a possible mechanism of chronic diabetic neuropathic pain,” Diabetes, vol. 34, pp. 1210–1213, 1985. View at Google Scholar
  41. M. Hirade, H. Yasuda, M. Omatsu-Kanbe, R. Kikkawa, and H. Kitasato, “Tetrodotoxin-resistant sodium channels of dorsal root ganglion neurons are readily activated in diabetic rats,” Neuroscience, vol. 90, pp. 933–939, 1999. View at Publisher · View at Google Scholar
  42. G. Xu and A. A. F. Sima, “Altered immediate early gene expression in injured diabetic nerve: implications in regeneration,” Journal of Neuropathology and Experimental Neurology, vol. 60, no. 10, pp. 972–983, 2001. View at Google Scholar
  43. D. N. Ishii, “Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy,” Brain Research Reviews, vol. 20, no. 1, pp. 47–67, 1995. View at Publisher · View at Google Scholar
  44. C. Wang, Y. Li, B. Wible, K. J. Angelides, and D. N. Ishii, “Effects of insulin and insulin-like growth factors on neurofilament mRNA and tubulin mRNA content in human neuroblastoma SH-SY5Y cells,” Molecular Brain Research, vol. 13, pp. 289–300, 1992. View at Publisher · View at Google Scholar
  45. M. K. Lee, Z. Xu, P. C. Wong, and D. W. Cleveland, “Neurofilaments are obligate heteropolymers in vivo,” Journal of Cell Biology, vol. 122, no. 6, pp. 1337–1350, 1993. View at Google Scholar
  46. P. Grant and H. C. Pant, “Neurofilament protein synthesis and phosphorylation,” Journal of Neurocytology, vol. 29, no. 11-12, pp. 843–872, 2000. View at Publisher · View at Google Scholar
  47. R. A. Nixon, P. A. Paskevich, R. K. Sihag, and C .Y. Thayer, “Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber,” Journal of Cell Biology, vol. 126, no. 4, pp. 1031–1046, 1994. View at Publisher · View at Google Scholar
  48. S. Guidato, L. H. Tsai, J. Woodgett, and C. C. J. Miller, “Differential cellular phosphorylation of neurofilament heavy side-arms by glycogen synthase kinase-3 and cydin-dependent kinase-5,” Journal of Neurochemistry, vol. 66, no. 4, pp. 1698–1706, 1996. View at Google Scholar
  49. M. Ubeda, D. M. Kemp, and J. F. Habener, “Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic β-cells,” Endocrinology, vol. 145, no. 6, pp. 3023–3031, 2004. View at Publisher · View at Google Scholar
  50. D. A. E. Cross, D. R. Alessi, J. R. Vandenheede, H. E. McDowell, H. S. Hundal, and P. Cohen, “The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf,” Biochemical Journal, vol. 303, no. 1, pp. 21–26, 1994. View at Google Scholar
  51. Z.-G. Li, W. Zhang, and A. A. F. Sima, “Alzheimer-like changes in rat models of spontaneous diabetes,” Diabetes, vol. 56, no. 7, pp. 1817–1824, 2007. View at Publisher · View at Google Scholar
  52. N. P. Bajaj and C. C. Miller, “Phosphorylation of neurofilament heavy-chain side-arm fragments by cyclin-dependent kinase-5 and glycogen synthase kinase-3alpha in transfected cells,” Journal of Neurochemistry, vol. 60, no. 2, pp. 737–743, 1997. View at Google Scholar
  53. B. I. Giasson and W. E. Mushynski, “Study of proline-directed protein kinases involved in phosphorylation of the heavy neurofilament subunit,” Journal of Neuroscience, vol. 17, no. 24, pp. 9466–9472, 1997. View at Google Scholar
  54. M. Deshmukh and E. M. Johnson Jr., “Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons,” Molecular Pharmacology, vol. 51, no. 6, pp. 897–906, 1997. View at Google Scholar
  55. A. A. F. Sima, A. C. Lorusso, and P. Thiert, “Distal symmetric polyneuropathy in the spontaneously diabetic BB-Wistar rat. An ultrastructural and teased fiber study,” Acta Neuropathologica, vol. 58, pp. 29–47, 1982. View at Google Scholar
  56. A. A. F. Sima, “Studies on fibre size in developing sciatic nerve and spinal roots in normal, undernourished and rehabilitated rats,” Acta Physiologica Scandinavica. Supplementum, vol. 406, pp. 1–55, 1974. View at Google Scholar
  57. B. Rexed, “Contributions to the knowledge of the postnatal development of the peripheral nervous system in man,” Acta Psychiatrica et Neurologica. Supplementum, vol. 33, 1944. View at Google Scholar